Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Trans Tasman Radiation Oncology Group (TROG)
Scientific Title
A Randomised Phase II Trial of Osimertinib With or Without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases